You have 9 free searches left this month | for more free features.

City

Bronx (1)

Chicago (1)

Memphis (1)

New York (1)

San Diego (1)

San Juan (1)

Washington (1)

Condition

HIV Infections (6)

Acquired Immunodeficiency Syndrome (3)

Overall Status

Completed (5)

Withdrawn (1)

Sign in for free

Phase

phase 2 (2)

phase 3 (2)

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Merck Sharp & Dohme LLC (4)

Merck Sharp & Dohme Corp. (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)

Intervention

vicriviroc (6)

placebo (2)

emtricitabine and tenofovir disoproxil fumarate (1)

Study Documents

Intervention Type

drug (6)

Funder Type

Industry (5)

NIH (1)

Study Type

Interventional (6)

vicriviroc

Showing 1 - 6 of 6

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

HIV Trial in Puerto Rico, United States (Vicriviroc)

Completed

HIV Infections

Vicriviroc

San Diego, California
+8 more

Nov 3, 2021

HIV, AIDS Trial (Vicriviroc)

Withdrawn

HIV Infections
Acquired Immunodeficiency Syndrome

Vicriviroc

(no location specified)

Sep 10, 2019

HIV, AIDS Trial (Vicriviroc, Placebo)

Completed

HIV Infections
Acquired Immunodeficiency Syndrome

Vicriviroc
Placebo

(no location specified)

Dec 18, 2015

HIV, AIDS Trial (Vicriviroc, Placebo)

Completed

HIV Infections
Acquired Immunodeficiency Syndrome

Vicriviroc
Placebo

(no location specified)

Sep 24, 2015

HIV Trial (Vicriviroc)

Completed

HIV Infections

Vicriviroc

(no location specified)

Feb 20, 2015

HIV Trial (Vicriviroc, emtricitabine and tenofovir disoproxil fumarate)

Completed

HIV Infections

Vicriviroc
emtricitabine and tenofovir disoproxil fumarate

(no location specified)

Feb 5, 2015